FDA warns about a risk of blood cancer in TNF blockers

04/14/2011 | Reuters

The FDA cautioned that a drug class called tumor necrosis factor inhibitors has been associated with hepatosplenic T-cell lymphoma, particularly among teens and young adults. A majority of the cases involved patients treated for ulcerative colitis or Crohn's disease. Labels have been updated for Johnson & Johnson's Remicade and Abbott Laboratories' Humira, the FDA said.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR CLINICAL RESEARCH - 14000003MB
Abbott
Santa Clara, CA
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA